VLCFA
Showing 1 - 16 of 16
Adrenomyeloneuropathy, Adrenoleukodystrophy Trial in L'Hospitalet de Llobregat (Albumin solution)
Completed
- Adrenomyeloneuropathy
- Adrenoleukodystrophy
- Albumin solution
-
L'Hospitalet de Llobregat, Barcelona, SpainBellvitge University Hospital
Sep 21, 2022
ALD (Adrenoleukodystrophy), Adrenoleukodystrophy, Cerebral Adrenoleukodystrophy Trial in Minneapolis (Medical Record
Recruiting
- ALD (Adrenoleukodystrophy)
- +2 more
- Medical Record Abstraction
- Biospecimen Sample Collection
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 22, 2022
Metachromatic Leukodystrophy, Adrenoleukodystrophy Trial in Shenzhen (transduced CD34+ hematopoietic stem cell)
Recruiting
- Metachromatic Leukodystrophy
- Adrenoleukodystrophy
- transduced CD34+ hematopoietic stem cell
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital, The First Affiliated Hospital
May 25, 2022
Adrenoleukodystrophy Trial in Baltimore (glyceryl trierucate/glyceryl trioleate)
Terminated
- Adrenoleukodystrophy
- glyceryl trierucate/glyceryl trioleate
-
Baltimore, Maryland
- +1 more
Oct 22, 2020
Zellweger Syndrome, Peroxisome Biogenesis Disorders Trial in Toronto (Hydroxychloroquine, Placebo)
Completed
- Zellweger Syndrome
- Peroxisome Biogenesis Disorders
- Hydroxychloroquine
- Placebo
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Dec 15, 2020
X-linked Adrenoleukodystrophy Trial in Leipzig (SMART-ALD, Waiting list)
Recruiting
- X-linked Adrenoleukodystrophy
- SMART-ALD
- Waiting list
-
Leipzig, Saxony, Germany
- +1 more
Aug 16, 2022
Quality of Life in Women With X-linked Adrenoleukodystrophy
Recruiting
- X-linked Adrenoleukodystrophy
-
Leipzig, Saxony, GermanyLeipzig University Medical Center, Leukodystrophy Outpatient Cli
Apr 4, 2022
X-linked Adrenoleukodystrophy Trial in Shenzhen (Intracerebral LV gene therapy)
Unknown status
- X-linked Adrenoleukodystrophy
- Intracerebral LV gene therapy
-
Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
Sep 18, 2019
Adrenomyeloneuropathy, X-linked Adrenoleukodystrophy Trial in L'Hospitalet de Llobregat, Donostia (Pioglitazone)
Completed
- Adrenomyeloneuropathy
- X-linked Adrenoleukodystrophy
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Sep 9, 2019
Prospectively Assess Disease Progression in Male X-ALD
Unknown status
- X-Linked Adrenoleukodystrophy
-
Palo Alto, California
- +2 more
Aug 7, 2018
X-linked Adrenoleukodystrophy Trial in Minneapolis (Lorenzo's Oil)
No longer available
- X-linked Adrenoleukodystrophy
- Lorenzo's Oil
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center
Jan 22, 2018
X-Linked Adrenoleukodystrophy, Adrenomyeloneuropathy Trial in Portland (Sobetirome)
Withdrawn
- X-Linked Adrenoleukodystrophy
- Adrenomyeloneuropathy
-
Portland, OregonOregon Health & Science University
Feb 12, 2014
X-linked Adrenoleukodystrophy, Adrenomyeloneuropathy Trial in Amsterdam (Bezafibrate)
Completed
- X-linked Adrenoleukodystrophy
- Adrenomyeloneuropathy
-
Amsterdam, NH, NetherlandsAcademisch Medisch Centrum
Aug 9, 2011
Adrenomyeloneuropathy, Adrenoleukodystrophy Trial in Baltimore (Lorenzo's oil)
Terminated
- Adrenomyeloneuropathy
- Adrenoleukodystrophy
- Lorenzo's oil
-
Baltimore, MarylandKennedy Krieger Institute
Mar 1, 2012